home / stock / pali / pali articles
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite falling more than 200 points on Thursday. Following the market opening Thur...
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) rose 39.7% to $1.25 in pre-market trading. American Rebel announced Wednesday, that its safe ...
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Wednesday. The Dow traded down 0.57% to 34,44...
U.S. stocks traded lower midway through trading, with the Dow Jones falling around 200 points on Wednesday. The Dow traded down 0.57% to 34,442.83 ...
Palisade Bio Inc (NASDAQ: PALI) shares are trading higher after the company announced a licensing agreement with Giiant Pharma ...
U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 50 points on Wednesday. Following the market opening Wednesday, the...
News, Short Squeeze, Breakout and More Instantly...
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors” with similar structure to PALI-2108 and PALI-1908 This patent family provides Composition o...
Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance Company has successfully formulated enteric-coated tablets of PALI-2108 and has demonstrated consistent and reliable drug release profiles Company on track to commence Ph...
Live video webcast on Wednesday, June 26 th at 4:00 PM ET Carlsbad, CA, June 24, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel...